🔗 Visit the ClinicalTrials.gov page for NCT00902174
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. | Circulation | 2013 | 2.64 |
| 2 | Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension. | Eur J Heart Fail | 2014 | 1.44 |
| 3 | Treatment of pulmonary arterial hypertension with targeted therapies. | Nat Rev Cardiol | 2011 | 1.08 |
| 4 | Systemic sclerosis-associated pulmonary arterial hypertension. | Chest | 2013 | 1.00 |
| 5 | Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? | BMC Pulm Med | 2011 | 0.92 |
| 6 | Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension. | Eur Heart J | 2014 | 0.85 |
| 7 | Update on pulmonary hypertension 2009. | Am J Respir Crit Care Med | 2010 | 0.83 |
| 8 | Right Atrial Function in Pulmonary Arterial Hypertension. | Circ Cardiovasc Imaging | 2015 | 0.82 |